Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study
暂无分享,去创建一个
A. Sweatt | K. Stenmark | M. Gomberg-Maitland | B. Maron | D. Kiely | V. Kheyfets | R. Condliffe | A. Lawrie | R. Zamanian | Dunbar Ivy | Dunbar D. Ivy | D. Ivy
[1] M. Humbert,et al. Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension. , 2022, American journal of respiratory and critical care medicine.
[2] Dennis Wang,et al. A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach , 2021, EBioMedicine.
[3] Sanjiv J. Shah,et al. STATE OF THE ART Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances , 2021 .
[4] M. Humbert,et al. Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype , 2021, European Respiratory Journal.
[5] M. Humbert,et al. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. , 2021, The New England journal of medicine.
[6] M. Wilkins. Personalized Medicine for Pulmonary Hypertension:: The Future Management of Pulmonary Hypertension Requires a New Taxonomy. , 2021, Clinics in chest medicine.
[7] O. Distler,et al. Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort , 2020, European Respiratory Journal.
[8] S. Mandras,et al. Pulmonary Hypertension: A Brief Guide for Clinicians. , 2020, Mayo Clinic proceedings.
[9] R. Benza,et al. Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension , 2020, Chest.
[10] Marek J Druzdzel,et al. Risk stratification in pulmonary arterial hypertension using Bayesian analysis , 2020, European Respiratory Journal.
[11] Hugh Chen,et al. From local explanations to global understanding with explainable AI for trees , 2020, Nature Machine Intelligence.
[12] Maarten van Smeden,et al. Calibration: the Achilles heel of predictive analytics , 2019, BMC Medicine.
[13] R. Benza,et al. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. , 2019, Chest.
[14] S. Rosenkranz,et al. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension , 2019, Herz.
[15] P. Khatri,et al. Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension , 2019, Circulation research.
[16] R. Singla,et al. Correlation of a modified shuttle walk with six-minute walk test in COPD patients , 2018, Clinical respiratory physiology, exercise and functional imaging.
[17] K. Malecki,et al. Using recursive feature elimination in random forest to account for correlated variables in high dimensional data , 2018, BMC Genetics.
[18] M. Humbert,et al. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study , 2017, The Lancet. Respiratory medicine.
[19] Scott Lundberg,et al. A Unified Approach to Interpreting Model Predictions , 2017, NIPS.
[20] Daniel D. Drevon,et al. Intercoder Reliability and Validity of WebPlotDigitizer in Extracting Graphed Data , 2017, Behavior modification.
[21] B. Michel,et al. Correlation and variable importance in random forests , 2016, Statistics and Computing.
[22] M. Humbert,et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.
[23] R. Speich,et al. Inflammatory cytokines in pulmonary hypertension , 2014, Respiratory Research.
[24] M. Humbert,et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension , 2013, European Respiratory Journal.
[25] R. Dweik,et al. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension , 2013, European Respiratory Journal.
[26] H. Turner,et al. Comparison of sample types for N-terminal pro-B-type natriuretic peptide measured on the Siemens Immulite 2500 and Dimension Vista LOCI methods , 2012, Annals of clinical biochemistry.
[27] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[28] M. Raza. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2011 .
[29] R. Trembath,et al. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.
[30] G. Lippi,et al. Measurement of Elecsys NT-proBNP in serum, K2 EDTA and heparin plasma. , 2007, Clinical biochemistry.
[31] Ramón Díaz-Uriarte,et al. Gene selection and classification of microarray data using random forest , 2006, BMC Bioinformatics.
[32] Rich Caruana,et al. Predicting good probabilities with supervised learning , 2005, ICML.
[33] Jun Chen,et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes , 2004, BMC Bioinformatics.
[34] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[35] Lloyd S. Shapley,et al. Notes on the n-Person Game — II: The Value of an n-Person Game , 1951 .